Beta-blocker monotherapy may be preferred for primary prophylaxis of esophageal variceal bleeding | ACP Gastroenterology Monthly
Guidelines currently recommend nonselective beta-blockers or variceal band ligation for primary prevention of variceal bleeding based on similar efficacy, but survival benefit may be better with the former treatment.
Opioid-induced constipation differs mechanistically from other forms of the disorder, and its medical management deserves dedicated attention, the American Gastroenterological Association (AGA) said.
PPI prophylaxis didn't affect 90-day mortality rates among ICU patients | ACP Gastroenterology Monthly
Gastrointestinal bleeds were less common among at-risk ICU patients who received IV pantoprazole instead of placebo, but rates of clinically important events were similar overall.
Antidepressants and psychological therapies reduce IBS symptoms, meta-analysis finds | ACP Gastroenterology Monthly
Psychological therapies were effective for irritable bowel syndrome (IBS) when delivered in person, whereas therapy that was self-administered, internet-based, or provided with minimal contact did not yield significant benefit.
Researchers calculated three pre-endoscopy scores—admission Rockall, AIMS65, and Glasgow Blatchford—and two postendoscopy scores—full Rockall and PNED.
Patients with stable Barrett's esophagus may need less surveillance, study finds | ACP Gastroenterology Monthly
The results could influence the number of endoscopies performed or extend the time between them, the authors noted.
The drug has been incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, which increases the risk of serious liver injury, the FDA said.
Antidepressants may mitigate link between inflammatory bowel disease and depression | ACP Gastroenterology Monthly
Patients with depression had more than double the risk of developing Crohn's disease or ulcerative colitis over a median follow-up of more than six years.
Patients with chronic hepatitis B virus (HBV) and hepatitis D virus (HDV) co-infection have the most severe form of viral hepatitis and are at much higher risk for cirrhosis and hepatocellular cancer than patients with HBV infection alone.
ACP Gastroenterology Monthly is pleased to introduce its editorial advisory board.